May 19, 2023 01:54 PM EDT
Pharma
Marketing

Eli Lil­ly re­news Twit­ter ac­tiv­i­ty with a new han­dle and 'lim­it­ed' ad­ver­tis­ing and post­ing

Beth Snyder Bulik

Senior Editor

Eli Lil­ly is back on Twit­ter with a new han­dle and lim­it­ed ad­ver­tis­ing and mes­sag­ing. Lil­ly pulled its Twit­ter ad­ver­tis­ing and stopped post­ing from its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times